Cellebrite DI Ltd.

03/18/2026 | Press release | Distributed by Public on 03/18/2026 06:28

Initial Statement of Beneficial Ownership (Form 3)

FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Tadmor-Eilat Zohar
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [CLBT]
(Last) (First) (Middle)
94 SHLOMO SHMELZER ROAD
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief People Officer
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
PETAH TIKVA 4970602
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Ordinary shares, par value NIS 0.00001 ("Ordinary Shares") 129,814(1)(2)(3)(4)(5) D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock options (6) 02/13/2033 Ordinary Shares 22,722 $4.95 D
Stock options (7) 03/19/2034 Ordinary Shares 28,236 $11.51 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Tadmor-Eilat Zohar
94 SHLOMO SHMELZER ROAD
PETAH TIKVA 4970602
Chief People Officer

Signatures

/s/ Zohar Tadmor-Eilat 03/18/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes 21,988 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on February 14, 2023, of which 5,497 vest on each of May 14, 2026 and every three months thereafter through February 14, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.
(2) Includes 15,615 Ordinary Shares that are represented by RSUs that were granted on March 20, 2024, of which 1,735 vest on each of March 20, 2026 and every three months thereafter through March 20, 2028.
(3) Includes 11,760 Ordinary Shares that are represented by RSUs that were granted on February 11, 2025, of which 980 vest on each of May 11, 2026 and every three months thereafter through February 11, 2029.
(4) Includes 3,471 Ordinary Shares that are represented by performance share units ("PSUs") that were granted on March 20, 2024, and vest based on the Issuer meeting certain total shareholder return thresholds for 60 consecutive trading days through March 20, 2028. Each PSU represents a contingent right to receive one Ordinary Share of the Issuer upon vesting and settlement.
(5) Includes 39,491 Ordinary Shares that are represented by RSUs that were granted on February 10, 2026 and vest as follows: 9,875 vest on the first anniversary of the grant date and 2,468 vest every three months thereafter through February 10, 2030.
(6) Of these stock options, 7,574 are fully vested and exercisable and 3,787 vest on each of May 14, 2026 and every three months thereafter through February 14, 2027.
(7) Of these stock options, 12,360 are fully vested and exercisable and 1,764 vest on each of March 20, 2026 and every three months thereafter through March 20, 2028.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Cellebrite DI Ltd. published this content on March 18, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 18, 2026 at 12:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]